Skip to main content

Cleminson Ian's Form 4 filing

Innospec Inc.IOSP · filed Feb 26, 2024

Accession no.
0000950170-24-020459
Filed
Feb 26, 2024
Trade date
Feb 22, 2024
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $518.6K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Cleminson IanCIK 0001368260Officer (VP & CFO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 22, 2024Common StockMOption exerciseAcquired+311$99.85+$31,053.3521,308Direct
Feb 22, 2024Common StockDReturned to the companyDisposed−311$123.96F1−$38,551.5620,997Direct
Feb 22, 2024Common StockAGrant or awardAcquired+4,190$0.00$025,187Direct
Feb 22, 2024Common StockSSaleDisposed−4,190$123.77−$518,596.320,997Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 22, 2024Common StockMOption exerciseDisposed−311$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Stock Appreciation Right. Vested on February 22, 2024. Vested rights were paid in cash on February 22, 2024 based upon the difference in the closing price of the Company's common stock on the date of grant ($99.85, on February 22, 2021) and on the date of exercise ($123.96, on February 22, 2024).

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)